The Federal Government has expressed confidence that Nigeria would secure a fair share of COVID-19 vaccine doses as soon as they are available.
The Minister of Health, Dr. Osagie Ehanire, made this known during the Presidential Task Force briefing on COVID-19 in Abuja, as the PTF criticised the move by some countries to nationalise and politicise vaccine distribution and accessibility, terming it as a failure of global leadership.
Nigeria is also working with World Health Organization (WHO) to finalize enrolment with ACT Accelerator, a global mechanism tracking and sponsoring research Organisations working on COVID-19 vaccine development.
We are also interested in the COVAX facility, a GAVI supported global initiative to procure and assure equitable access to vaccines, as soon as they are available, especially for lower middle Income Countries (LMIC). This will prioritize Nigeria for allocation of a part of 2 billion vaccines doses that will be secured, in a special plan to protect the interests of poorer countries.
The changing dynamics of the virus and the disease make it necessary for us to continue to review our response strategies, ensure we train and update our health workers on the latest and most effective approach to treatment of the disease and tailor our procurement in the light of knowledge gained.
The Information session on COVID-19, conducted weekly by the World Health Organization (WHO) was held this morning. I had the opportunity of sharing our experience in Nigeria, as one of two countries invited to make presentations on our response strategies.
A clear message from this briefing is that COVID-19 is a threat to mankind and there is need for all countries to work together for solutions that will allow equitable access. In the words of the Director General of the WHO, Dr. Tedros Ghebreyesus, ‘By working together, we are protecting each other. In a global pandemic, none of us is safe until all of us are safe.
Recall that Russia recently announced that it had become the first country to find a cure to the COVID-19 pandemic.